MétaCan
Menu
Back to cohort
Record W2044184552 · doi:10.4212/cjhp.v64i2.1004

Pediatric Pharmacokinetics of Vancomycin: A Canadian Perspective

2011· article· en· W2044184552 on OpenAlexaffvenueabout
Anais Delicourt, Jean‐François Bussières, Denis Lebel

Bibliographic record

VenueThe Canadian Journal of Hospital Pharmacy · 2011
Typearticle
Languageen
FieldMedicine
TopicAntibiotics Pharmacokinetics and Efficacy
Canadian institutionsCentre Hospitalier Universitaire Sainte-Justine
Fundersnot available
KeywordsVancomycinPharmacokineticsPerspective (graphical)MedicinePharmacologyComputer scienceBiologyStaphylococcus aureus

Abstract

fetched live from OpenAlex

or cardiovascular death, so it would have been more appropriate to refer to a reduction in the incidence of myocardial infarction, as opposed to cardiovascular events.Our third issue of concern relates to the data for myocardial infarction, which was 1 of 3 outcomes measured in the study.The authors reported a 0.6% reduction in this outcome among patients assigned to receive double-dose clopidogrel, relative to those receiving the standard dose.There are 2 reasons why we question the clinical importance of this result.First, the effect size was small and of debatable clinical importance.Second, it is possible that this finding is a false positive (type 1 error), as no p value adjustment was made for the multiple comparisons performed in the trial.4 The authors also used a postrandomization subgroup of the overall trial population, which leads to additional risk of a type 1 error.5 Our fourth issue of concern is the lack of reporting of harm in the conclusion statements of the abstract and the full article, which might lead a reader to believe that there are no risks associated with the double-dose regimen.In fact, the incidence of major bleeding (as defined by the CURRENT-OASIS 7 authors) was higher in the double-dose group than the standard-dose group (1.6% versus 1.1%, hazard ratio 1.41, 95% confidence interval 1.09-1.83,p = 0.009). 2 This represents a 0.5% absolute increase in the hazard of harm (major bleeding).The omission of this information from the concluding statements appears to be selective reporting, which is misleading.Our final issue of concern relates to the overall assessment of harm versus benefit.Specifically, the 0.6% reduction in risk of myocardial infarction would seem to be nullified by the 0.5% increase in the risk of major bleeding.Although some would argue that the benefit of preventing myocardial infarction outweighs the risk of a major bleeding event, these 2 outcomes are only a subset of the possible effects of the double-dose regimen.Returning to our first issue of concern, described above, a full analysis of serious adverse events could help in determining the net effect of the double-dose regimen and provide more confidence in saying whether the benefit outweighs the risk.Does this study provide enough information to support a double-dose regimen of clopidogrel?We're not convinced.Does something need to be done about the selective reporting of harm in conclusion statements?Absolutely.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.140
Threshold uncertainty score0.282

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.006
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.002
Science and technology studies0.0010.002
Scholarly communication0.0030.001
Open science0.0010.001
Research integrity0.0030.006
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.034
GPT teacher head0.287
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2011
Admission routes3
Has abstractyes

Explore more

Same venueThe Canadian Journal of Hospital PharmacySame topicAntibiotics Pharmacokinetics and EfficacyFrench-language works237,207